Factors Associated with Diabetic Complication Index among Type 2 Diabetes Patients: Focusing on Regular Outpatient Follow-up and HbA1c Variability

被引:1
|
作者
Lee, Haejung [1 ]
Park, Gaeun [1 ,3 ]
Khang, Ah Reum [2 ]
机构
[1] Pusan Natl Univ, Coll Nursing, Yangsan 602739, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan, South Korea
[3] Pusan Natl Univ, 414 Coll Nursing, 49 Busandaehak Ro Mulgeum Eup, Yangsan 50612, South Korea
基金
新加坡国家研究基金会;
关键词
ambulatory care; diabetes complications; diabetes mellitus; type; 2; glycated hemoglobin; OUTCOMES; FREQUENCY;
D O I
10.1016/j.anr.2023.11.004
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Purpose: Preventing diabetic complications involves regular outpatient follow-up and maintaining low variability in hemoglobin A1c (HbA1c) levels. This study investigated the factors associated with diabetic complications, with a specific focus on the impact of regular outpatient follow-up and HbA1c variability, among patients with type 2 diabetes. Methods: The study design was secondary data analysis of electronic medical records from a university hospital in Korea. It included patients aged 40-79 with type 2 diabetes who were prescribed diabetes medication within three months of their first HbA1c test by an endocrinologist and were followed up for at least five years. Follow-up regularity, adjusted standard deviation of HbA1c levels, and diabetic complication indices were collected. Data were analyzed using the Chi-square test, independent t-test, repeated measures analysis of variance, and multiple regression analysis. Results: The study included 1566 patients. Lower follow-up regularity was observed in patients of older age, with comorbidities, diabetic complications, insulin treatment, a history of hospitalization, lower baseline estimated glomerular filtration rate (eGFR) and total cholesterol (TC), and higher HbA1c variability. Higher HbA1c variability was observed in younger patients without comorbidity but with insulin treatment, a history of hospitalization, higher baseline blood glucose (BG), HbA1c, TC, and triglyceride levels. HbA1c variability had the strongest influence on BG and HbA1c levels at the five-year follow-up. Baseline eGFR and TC were the most influential factors for their respective levels at the five-year followup. Follow-up regularity significantly affected BG, HbA1c, eGFR, and TC at five-year follow-up. Conclusions: It has been shown that several variables besides regular follow-up and HbA1c variability have an influence. However, these are the two that can be corrected through nursing intervention and are important, so intervention on these is important. (c) 2023 Korean Society of Nursing Science. Published by Elsevier BV. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:259 / 268
页数:10
相关论文
共 50 条
  • [21] Sociodemographic factors associated with HbA1c variability in type 2 diabetes: a prospective exploratory cohort study
    Mellergard, Emelia
    Johnsson, Per
    Eek, Frida
    BMC ENDOCRINE DISORDERS, 2020, 20 (01)
  • [22] HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes
    Hu, Jiaqi
    Hsu, Huichun
    Yuan, Xiaodan
    Lou, Kezheng
    Hsue, Cunyi
    Miller, Joshua D.
    Lu, Juming
    Lee, Yaujiunn
    Lou, Qingqing
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (06) : 1229 - 1236
  • [23] HbA1c variability is independently associated with progression of diabetic kidney disease in people with type 1 diabetes
    Muthukumar, A.
    Badawy, L.
    Mangelis, A.
    Vas, P.
    Thomas, S.
    Gouber, A.
    Ayis, S.
    Karalliedde, J.
    DIABETOLOGIA, 2024, 67 : S88 - S88
  • [24] Association between HbA1c variability and mortality in patients with type 2 diabetes
    Takao, Toshiko
    Matsuyama, Yutaka
    Yanagisawa, Hiroyuki
    Kikuchi, Masatoshi
    Kawazu, Shoji
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (04) : 494 - 499
  • [25] Characteristics of patients with low and high HbA1c variability in type 2 diabetes
    Noyes, J. D.
    Soto-Pedre, E.
    Donnelly, L. A.
    Lonergan, M.
    Zhou, K.
    Pearson, E. R.
    DIABETOLOGIA, 2016, 59 : S61 - S62
  • [26] Hyperuricaemia is associated with dyslipidemia but not HbA1c among type 2 diabetes mellitus patients in Botswana
    Gobusamang, Ellen
    Nyepetsi, Naledi G.
    Motswaledi, Modisa S.
    Kasvosve, Ishmael
    AFRICAN JOURNAL OF LABORATORY MEDICINE, 2019, 8 (01)
  • [27] Improvements in HbA1c remain after 5 years -: a follow up of an educational intervention focusing on patients' personal understandings of type 2 diabetes
    Hornsten, Asa
    Stenlund, Hans
    Lundman, Berit
    Sandstrom, Herbert
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (01) : 50 - 55
  • [28] Contributing factors associated with long-term variability of HbA1c in patients with type 2 diabetes: a real world analysis
    Matsutani, D.
    Tsujimoto, Y.
    Minato, S.
    Ukichi, R.
    Nishikawa, M.
    Sakamoto, M.
    DIABETOLOGIA, 2019, 62 : S178 - S178
  • [29] Effect of mean HbA1c on the association of HbA1c variability and all-cause mortality in patients with type 2 diabetes
    Tseng, Juei-Yu
    Chen, Hsin-Hung
    Huang, Kuo-Chin
    Hsu, Sheng-Pang
    Chen, Ching-Chu
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 680 - 687
  • [30] Effects of finerenone in patients with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability and duration of diabetes
    McGill, J. B.
    Agarwal, R.
    Anker, S. D.
    Bakris, G. L.
    Filippatos, G.
    Pitt, B.
    Ruilope, L. M.
    Birkenfeld, A. L.
    Caramori, M. L.
    Brinker, M.
    Joseph, A.
    Lage, A.
    Lawatscheck, R.
    Scott, C.
    Rossing, P.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S318 - S318